NBI-34041

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNBI-34041
Drug Alias NameSB-723620NBI-34041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsAnxietyDepressionIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsAnxietyDepressionIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A